IRadimed Corporation

Symbol: IRMD

NASDAQ

44.57

USD

Market price today

  • 29.6251

    P/E Ratio

  • 0.1514

    PEG Ratio

  • 564.38M

    MRK Cap

  • 0.02%

    DIV Yield

IRadimed Corporation (IRMD) Stock Price & Analysis

Shares Outstanding

12.66M

Gross Profit Margin

0.77%

Operating Profit Margin

0.31%

Net Profit Margin

0.26%

Return on Assets

0.19%

Return on Equity

0.25%

Return on Capital Employed

0.26%

Company general description and statistics

Sector: Healthcare
Industry: Medical Devices
CEO:Mr. Roger E. Susi
Full-time employees:148
City:Winter Springs
Address:1025 Willa Springs Drive
IPO:2014-07-16
CIK:0001325618

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

General Outlook

In simple terms, IRadimed Corporation has 12.663 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.765% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.306%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.262%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.187% return, is a testament to IRadimed Corporation's adeptness in optimizing resource deployment. IRadimed Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.246%. Furthermore, the proficiency of IRadimed Corporation in capital utilization is underscored by a remarkable 0.264% return on capital employed.

Stock Prices

IRadimed Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $44.35, while its low point bottomed out at $42.68. This variance in figures offers investors a lucid insight into the roller-coaster ride that is IRadimed Corporation's stock market.

Liquidity Ratios

Analyzing IRMD liquidity ratios reveals its financial health of the firm. The current ratio of 465.48% gauges short-term asset coverage for liabilities. The quick ratio (379.65%) assesses immediate liquidity, while the cash ratio (304.78%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio465.48%
Quick Ratio379.65%
Cash Ratio304.78%

Profitability Ratios

IRMD profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 33.16% underscores its earnings before tax deductions. The effective tax rate stands at 20.91%, revealing its tax efficiency. The net income per EBT, 79.09%, and the EBT per EBIT, 108.50%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 30.56%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin33.16%
Effective Tax Rate20.91%
Net Income per EBT79.09%
EBT per EBIT108.50%
EBIT per Revenue30.56%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 4.65, it details the span from stock purchase to revenue. The 4 days it takes to settle debts showcases its creditor relations. Meanwhile, a 3 cash conversion cycle and 536.33% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding380
Days of Inventory Outstanding304
Operating Cycle371.85
Days of Payables Outstanding44
Cash Conversion Cycle328
Receivables Turnover5.36
Payables Turnover8.29
Inventory Turnover1.20
Fixed Asset Turnover5.79
Asset Turnover0.71

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1.07, and free cash flow per share, 0.43, depict cash generation on a per-share basis. The cash per share value, 3.94, showcases liquidity position. A payout ratio of 1.54 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.21, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share1.07
Free Cash Flow per Share0.43
Cash per Share3.94
Payout Ratio1.54
Operating Cash Flow Sales Ratio0.21
Free Cash Flow to Operating Cash Flow Ratio0.41
Cash Flow Coverage Ratio6.59
Short Term Coverage Ratio31.46
Capital Expenditure Coverage Ratio1.68
Dividend Paid and Capex Coverage Ratio0.39
Dividend Payout Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 2.22%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.03, we discern the balance between debt and equity financing. The long-term debt to capitalization, 2.21%, and total debt to capitalization, 2.78%, ratios shed light on its capital structure.

cards.indicatorcards.value
Debt Ratio2.22%
Debt Equity Ratio0.03
Long Term Debt to Capitalization2.21%
Total Debt to Capitalization2.78%
Cash Flow to Debt Ratio6.59
Company Equity Multiplier1.29

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 5.20, provides a glimpse into top-line earnings distributed across each share. Net income per share, 1.36, reflects the portion of profit attributed to each share. The book value per share, 5.67, represents the net asset value distributed per share, while the tangible book value per share, 5.47, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share5.20
Net Income Per Share1.36
Book Value Per Share5.67
Tangible Book Value Per Share5.47
Shareholders Equity Per Share5.67
Interest Debt Per Share0.16
Capex Per Share-0.64

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 23.00%, indicates top-line expansion, while the gross profit growth, 21.50%, reveals profitability trends. EBIT growth, 28.21%, and operating income growth, 28.21%, offer insights into operational profitability progression. The net income growth, 34.03%, showcases bottom-line expansion, and the EPS growth, 33.33%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth23.00%
Gross Profit Growth21.50%
EBIT Growth28.21%
Operating Income Growth28.21%
Net Income Growth34.03%
EPS Growth33.33%
EPS Diluted Growth32.35%
Weighted Average Shares Growth0.32%
Weighted Average Shares Diluted Growth0.69%
Dividends per Share Growth-100.00%
Operating Cash Flow Growth34.08%
Free Cash Flow Growth162.89%
10-Year Revenue Growth per Share377.82%
5-Year Revenue Growth per Share83.87%
3-Year Revenue Growth per Share98.85%
10-Year Operating CF Growth per Share654.78%
5-Year Operating CF Growth per Share55.84%
3-Year Operating CF Growth per Share122.65%
10-Year Net Income Growth per Share633.62%
5-Year Net Income Growth per Share132.84%
3-Year Net Income Growth per Share1108.09%
R&D Expense Growth25.49%
SGA Expenses Growth16.63%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 550,542,786.56, captures the company's total value, considering both debt and equity. Income quality, 0.78, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.23, gauges operational efficiency, while the research and development to revenue, 4.36%, highlights investment in innovation. The ratio of intangibles to total assets, 2.73%, indicates the value of non-physical assets, and capex to operating cash flow, -59.47%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value550,542,786.56
Income Quality0.78
Sales General and Administrative to Revenue0.23
Research and Development to Revenue4.36%
Intangibles to Total Assets2.73%
Capex to Operating Cash Flow-59.47%
Capex to Revenue-12.21%
Capex to Depreciation-1046.44%
Stock-Based Compensation to Revenue3.34%
Graham Number13.19
Return on Tangible Assets19.18%
Graham Net Net3.54
Working Capital59,673,806
Tangible Asset Value68,901,111
Net Current Asset Value55,265,178
Average Receivables12,749,397
Average Payables1,828,203.5
Average Inventory9,095,213.5
Days Sales Outstanding68
Days Payables Outstanding44
Days of Inventory On Hand304
ROIC21.57%
ROE0.24%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 7.13, and the price to book ratio, 7.13, reflect the market's valuation relative to the company's book value. The price to sales ratio, 7.80, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 93.64, and price to operating cash flows, 37.83, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio7.13
Price to Book Ratio7.13
Price to Sales Ratio7.80
Price Cash Flow Ratio37.83
Price Earnings to Growth Ratio0.15
Enterprise Value Multiple27.38
Price Fair Value7.13
Price to Operating Cash Flow Ratio37.83
Price to Free Cash Flows Ratio93.64
Price to Tangible Book Ratio8.38
Enterprise Value to Sales8.40
Enterprise Value Over EBITDA26.47
EV to Operating Cash Flow40.89
Earnings Yield2.87%
Free Cash Flow Yield0.91%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of IRadimed Corporation (IRMD) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 29.625 in 2024.

What is the ticker symbol of IRadimed Corporation stock?

The ticker symbol of IRadimed Corporation stock is IRMD.

What is company IPO date?

IPO date of IRadimed Corporation is 2014-07-16.

What is company current share price?

Current share price is 44.570 USD.

What is stock market cap today?

The market cap of stock today is 564380996.000.

What is PEG ratio in 2024?

The current 0.151 is 0.151 in 2024.

What is the number of employees in 2024?

In 2024 the company has 148.